StockVS

TSX · Health Information Services · CAD

NetraMark Holdings Inc. (AIAI.TO) Stock Analysis

NetraMark Holdings Inc. (AIAI.TO) is a Health Information Services stock listed on TSX and quoted in Canadian Dollar.

Last Updated: October 21, 2026

AIAI.TO

CA$0.59

CA$0.00 (0.00%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AIAI.TO with… →

AIAI.TO Key Statistics

As of Oct 21, 2026
Trading
Open
CA$0.64
Previous Close
CA$0.59
Day's Range
0.59–0.64
52-Week Range
0.58–1.38
Volume
68.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.40
Valuation
Market Cap
CA$55.83M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
92.13
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.07
Financials (FY)
Revenue (FY)
CA$432.50K−5.18%
Net Income (FY)
−CA$5.22M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
94.63M
1-Year Return
−57.25%
Dividend and dates
Avg Volume
33.33K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AIAI.TO closed at CA$0.59, −57.25% over 1 year.

NetraMark Holdings Inc. (AIAI.TO) has a market capitalization of CA$55.83M.

In fiscal 2025, AIAI.TO reported revenue of CA$432.50K.

AIAI.TO Stock Return by Calendar Year

NetraMark Holdings Inc. (AIAI.TO) return since Jun 2021: what CA$10,000 became

1 year
CA$10,000 CA$4,275
−57.25%
5 years
CA$10,000 CA$3,576
−64.24%
Since Jun 2021
CA$10,000 CA$2,682
−73.18%

If you had invested CA$10,000 in NetraMark Holdings Inc. (AIAI.TO) at the close on June 10, 2021, the earliest close on record here, it would have been worth CA$2,682 at the close on October 21, 2026: −73.18% in total, −21.76% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−46.36%
2025+10.00%
2024+185.71%
2023+105.88%
2022−84.55%
2021 (partial year)−50.00%

As of October 21, 2026.

AIAI.TO Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025CA$432.50K−CA$5.22M−1,207.3%
2024CA$456.13K−CA$3.33M−730.5%
2023CA$89.27K−CA$14.17M−15,872.7%
2022CA$113.03K−CA$13.45M−11,897.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$432.50K—−CA$5.22M−CA$5.22M−1,207.3%
2024CA$456.13K—−CA$3.33M−CA$3.33M−730.5%
2023CA$89.27K—−CA$5.86M−CA$14.17M−15,872.7%
2022CA$113.03K—−CA$7.93M−CA$13.45M−11,897.3%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

AIAI.TO Valuation vs Health Information Services Median

Median of 44 stocks
MetricAIAI.TOHealth Information Services medianvs median
P/S ratio92.132.3139.9x the median

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

The market values NetraMark Holdings Inc. (AIAI.TO) at CA$55.83M. It is classified in the Health Information Services industry, within the Healthcare sector.

Over the past 52 weeks the price has ranged from CA$0.58 to CA$1.38. The most recent close on file for AIAI.TO is CA$0.59, dated October 21, 2026. The close was unchanged from the previous session. The latest close sits 1.72% above that 52-week low.

Financial Health

In fiscal 2025, NetraMark Holdings Inc. reported revenue of CA$432.50K. That is −5.18% against the prior fiscal year, when revenue was CA$456.13K. The same year closed with a net loss of CA$5.22M. Earnings per share on a trailing basis come to −0.07.

Across the 4 fiscal years on file, revenue moves from CA$113.03K in 2022 to CA$432.50K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 92.13 times revenue. On price-to-sales that is 39.9 times the Health Information Services median of 2.31. The medians here are taken across 44 Health Information Services companies that report the metric.

Over the trailing twelve months the total return is −57.25%. Across 5 years the annualized return works out at −18.59%. Beta against the wider market is reported at 1.4. Annualized volatility over the trailing 5 years is 106%.

Growth & Income

The record shows no dividend for AIAI.TO.

2026 is still running; the total return is −46.36% year to date. The strongest complete calendar year on file is 2024 at +185.71%; the weakest is 2022 at −84.55%. Of the 4 complete calendar years on file, 3 finished higher.

Peer Comparison

NetraMark Holdings Inc. (AIAI.TO) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
NetraMark Holdings Inc. AIAI.TO CA$55.83M —
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Health Information Services industry average P/E ratio is 46.5x. NetraMark Holdings Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About NetraMark Holdings Inc.

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

Visit website →